Propranolol in the treatment of hypertension.

With heightened awareness of the need for better treatment of millions of hypertensive patients, physicians have markedly increased their use of antihypertensive drugs in the past few years. Empiri...

[1]  S. Julius,et al.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. , 2009, Acta medica Scandinavica.

[2]  O. Andersson,et al.  Propranolol given twice daily in hypertension. , 2009, Acta medica Scandinavica.

[3]  J. Castenfors,et al.  Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. , 2009, Acta medica Scandinavica.

[4]  T. Yü,et al.  Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. , 1975, The American journal of medicine.

[5]  R. Miller,et al.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. , 1975, The New England journal of medicine.

[6]  A. Zanchetti,et al.  Studies of the Absorption and Removal of Propranolol in Hypertensive Patients during Therapy , 1975, Circulation.

[7]  H. L. Garvey,et al.  Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs. , 1975, The Journal of pharmacology and experimental therapeutics.

[8]  D. Shand,et al.  Clinical Pharmacology of Propranolol , 1975, Circulation.

[9]  F. Leenen,et al.  Effect of Salt Depletion and Propranolol on Blood Pressure and Plasma Renin Activity in Various Forms of Hypertension , 1975, Circulation research.

[10]  W. Ganong,et al.  Studies concerning the mechanism of suppression of renin secretion by clonidine. , 1975, The Journal of pharmacology and experimental therapeutics.

[11]  C. Dollery,et al.  Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. , 1975, The Journal of pharmacology and experimental therapeutics.

[12]  G. Johnsson,et al.  Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate. , 1975, British medical journal.

[13]  R. Tarazi,et al.  β-Adrenergic Blockade in Diuretic-Treated Patients with Essential Hypertension , 1975 .

[14]  M. Weber,et al.  Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. , 1974, The Journal of clinical investigation.

[15]  R. Tarazi,et al.  Cardioadrenergic factor in essential hypertension. , 1974, American heart journal.

[16]  P. Weidmann,et al.  Plasma renin and blood pressure during treatment with methyldopa. , 1974, The American journal of cardiology.

[17]  J. Laragh,et al.  An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. , 1974, The New England journal of medicine.

[18]  E. Smith,et al.  Propranolol in the management of hypertension in a long-term dialysis program. , 1974, JAMA.

[19]  F. Thompson,et al.  Letter: Beta-blockade in the presence of renal disease and hypertension. , 1974, British medical journal.

[20]  H. Aberg.  Letter: Beta receptors and renin release. , 1974, The New England journal of medicine.

[21]  W. Louis,et al.  A comparison of beta adrenergic blocking drugs in the treatment of hypertension , 1974 .

[22]  M. Esler.  Effect of practolol on blood pressure and renin release in man , 1974, Clinical pharmacology and therapeutics.

[23]  D. Warren,et al.  Deterioration in Renal Function after Beta-blockade in Patients with Chronic Renal Failure and Hypertension , 1974, British medical journal.

[24]  R. Branch,et al.  Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. , 1974, The Journal of clinical investigation.

[25]  P. Kincaid‐smith,et al.  DOUBLE‐BLIND COMPARISON OF TWO BETA‐BLOCKING DRUGS WITH PREVIOUS THERAPY IN THE TREATMENT OF HYPERTENSION , 1974, The Medical journal of Australia.

[26]  A. Amery,et al.  Letter: Beta receptors and renin release. , 1974, The New England journal of medicine.

[27]  M. Weber,et al.  β-Blockers and Plasma Renin Activity in Hypertension , 1974 .

[28]  J. Laragh,et al.  Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. , 1973, Lancet.

[29]  J. Laragh,et al.  Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. , 1973, The American journal of cardiology.

[30]  J. Laragh,et al.  Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. , 1973, The American journal of cardiology.

[31]  D. Shand,et al.  Hypertensive response to propranolol in a patient treated with methyldopa—a proposed mechanism , 1973, Clinical pharmacology and therapeutics.

[32]  W. E. Fann,et al.  Antagonism of guanethidine by chlorpromazine. , 1973, The American journal of psychiatry.

[33]  W. Campbell,et al.  Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat , 1973, Circulation research.

[34]  D. Shand,et al.  Disposition of propranolol V. Drug accumulation and steady‐state concentrations during chronic oral administration in man , 1973, Clinical pharmacology and therapeutics.

[35]  A. J. Reyes.  Propranolol and the hyperactive carotid sinus reflex syndrome. , 1973, British medical journal.

[36]  S. Podolsky,et al.  Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy. , 1973, Metabolism: Clinical and Experimental.

[37]  N. Singh,et al.  Central cardiovascular effects of intracerebroventricular propranolol. , 1973, European journal of pharmacology.

[38]  H. Ibsen,et al.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. , 1973, Clinical science.

[39]  T. B. Schwartz,et al.  Propranolol-induced Insulin Release in Isolated Rat Islets of Langerhans , 1973, Diabetes.

[40]  J. Mackinnon,et al.  Propranolol and polythiazide in treatment of hypertension. , 1972, British heart journal.

[41]  W. Birkenhäger,et al.  Effects of chronic beta-adrenergic blockade on systemic and renal haemodynamic responses to hyperosmotic saline in hypertensive patients. , 1972, Clinical science.

[42]  H. Ibsen,et al.  Plasma volume and extracellular fluid volume during long-term treatment with propranolol in essential hypertension. , 1972, Clinical science.

[43]  R. Wray,et al.  Propranolol-induced hypoglycaemia and myocardial infarction. , 1972, British medical journal.

[44]  J. Vickers,et al.  Propranolol in hypertension: a study of long-term therapy, 1964-1970. , 1972, American heart journal.

[45]  F. Thompson,et al.  Pharmacodynamics of Propranolol in Renal Failure , 1972, British medical journal.

[46]  M. Ackenheil,et al.  Propranolol therapy in essential hypertension. , 1972, American heart journal.

[47]  R. Tarazi,et al.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. , 1972, The American journal of cardiology.

[48]  J. Laragh,et al.  Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. , 1972, The American journal of medicine.

[49]  J. Koch-weser,et al.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. , 1972, The New England journal of medicine.

[50]  W. Birkenhäger,et al.  Consecutive haemodynamic patterns in essential hypertension. , 1972, Lancet.

[51]  J. Laragh,et al.  Essential hypertension: renin and aldosterone, heart attack and stroke. , 1972, The New England journal of medicine.

[52]  A. Michelakis,et al.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man. , 1972, The Journal of clinical endocrinology and metabolism.

[53]  E. Frohlich,et al.  Plasma volume changes with long-term beta-adrenergic blockade. , 1971, American heart journal.

[54]  D. Beevers,et al.  The long-term treatment of hypertension with thiazide diuretics , 1971, Postgraduate medical journal.

[55]  D. Shand,et al.  Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man , 1970, British medical journal.

[56]  G. Kelliher,et al.  Central hypotensive activity of dl- and d-propranolol. , 1970, Journal of pharmaceutical sciences.

[57]  J. Weil,et al.  Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. , 1970, The New England journal of medicine.

[58]  A. Freedman,et al.  Adrenergic receptor mediation of renin secretion. , 1969, The Journal of clinical endocrinology and metabolism.

[59]  E. Cerasi,et al.  Role of adrenergic receptors in glucose-induced insulin secretion in man. , 1969, Lancet.

[60]  P. Gillam,et al.  Treatment of Hypertension with Propranolol , 1969, British medical journal.

[61]  S. N. Tewari,et al.  Propranolol in hypertension. , 1968, British medical journal.

[62]  G. Humphreys,et al.  Ineffectiveness of propranolol in hypertensive Jamaicans. , 1968, British medical journal.

[63]  D. Richardson,et al.  Effect of Propranolol on Elevated Arterial Blood Pressure , 1968, Circulation.

[64]  E. Frohlich,et al.  The Paradox of Beta‐Adrenergic Blockade in Hypertension , 1968, Circulation.

[65]  J. Hamer,et al.  Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease. , 1967, Lancet.

[66]  M. Kotler,et al.  HYPOGLYCÆMIA PRECIPITATED BY PROPRANOLOL , 1966 .

[67]  C. Dollery,et al.  Effect of propranolol in mild hypertension. , 1966, Lancet.

[68]  B. Prichard,et al.  Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma. , 1966, The American journal of cardiology.

[69]  H. Waal.  Hypotensive action of propranolol , 1966, Clinical pharmacology and therapeutics.

[70]  E. Braunwald,et al.  Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. , 1965, The Journal of clinical investigation.

[71]  E. S. Kristiansen.  CARDIAC COMPLICATIONS DURING TREATMENT WITH IMIPRAMIN (TOFRANIL) , 1961, Acta psychiatrica Scandinavica.

[72]  K. Terplán,et al.  The Kidney in Gout , 1960, Medicine.

[73]  Humphries Sv.  A study of hypertension in the Bahamas. , 1957 .

[74]  W. Hollander,et al.  Observations on Angina Pectoris during Drug Treatment of Hypertension , 1956, Circulation.

[75]  H. Perry.  Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. , 1973, The American journal of medicine.

[76]  A. Michelakis,et al.  Renin Secretion, Adrenergic Blockade and Hypertension , 1972 .